» Articles » PMID: 35539386

A Machine Learning Approach Towards the Prediction of Protein-ligand Binding Affinity Based on Fundamental Molecular Properties

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 11
PMID 35539386
Authors
Affiliations
Soon will be listed here.
Abstract

There is an exigency of transformation of the enormous amount of biological data available in various forms into some significant knowledge. We have tried to implement Machine Learning (ML) algorithm models on the protein-ligand binding affinity data already available to predict the binding affinity of the unknown. ML methods are appreciably faster and cheaper as compared to traditional experimental methods or computational scoring approaches. The prerequisites of this prediction are sufficient and unbiased features of training data and a prediction model which can fit the data well. In our study, we have applied Random forest and Gaussian process regression algorithms from the Weka package on protein-ligand binding affinity, which encompasses protein and ligand binding information from PdbBind database. The models are trained on the basis of selective fundamental information of both proteins and ligand, which can be effortlessly fetched from online databases or can be calculated with the availability of structure. The assessment of the models was made on the basis of correlation coefficient ( ) and root mean square error (RMSE). The Random forest model gave and RMSE of 0.76 and 1.31 respectively. We have also used our features and prediction models on the dataset used by others and found that our model with our features outperformed the existing ones.

Citing Articles

Narrowing the gap between machine learning scoring functions and free energy perturbation using augmented data.

Valsson I, Warren M, Deane C, Magarkar A, Morris G, Biggin P Commun Chem. 2025; 8(1):41.

PMID: 39922899 PMC: 11807228. DOI: 10.1038/s42004-025-01428-y.


Advances in Protein-Ligand Binding Affinity Prediction via Deep Learning: A Comprehensive Study of Datasets, Data Preprocessing Techniques, and Model Architectures.

Abdelkader G, Kim J Curr Drug Targets. 2024; 25(15):1041-1065.

PMID: 39318214 PMC: 11774311. DOI: 10.2174/0113894501330963240905083020.


DOCK-PET: database of CNS kinetic parameters in the healthy human brain for existing PET tracers.

Miyajima I, Yoshikawa A, Sahashi K, Seki C, Nagai Y, Watabe H Ann Nucl Med. 2024; 38(8):666-672.

PMID: 38814564 DOI: 10.1007/s12149-024-01947-z.


Drug Repurposing: Insights into Current Advances and Future Applications.

Bhatia T, Sharma S Curr Med Chem. 2023; 32(3):468-510.

PMID: 37946344 DOI: 10.2174/0109298673266470231023110841.


In-Silico Approaches for the Screening and Discovery of Broad-Spectrum Marine Natural Product Antiviral Agents Against Coronaviruses.

Boswell Z, Verga J, Mackle J, Guerrero-Vazquez K, Thomas O, Cray J Infect Drug Resist. 2023; 16:2321-2338.

PMID: 37155475 PMC: 10122865. DOI: 10.2147/IDR.S395203.


References
1.
Kim S, Thiessen P, Bolton E, Chen J, Fu G, Gindulyte A . PubChem Substance and Compound databases. Nucleic Acids Res. 2015; 44(D1):D1202-13. PMC: 4702940. DOI: 10.1093/nar/gkv951. View

2.
Anderson A . The process of structure-based drug design. Chem Biol. 2003; 10(9):787-97. DOI: 10.1016/j.chembiol.2003.09.002. View

3.
Deng W, Breneman C, Embrechts M . Predicting protein-ligand binding affinities using novel geometrical descriptors and machine-learning methods. J Chem Inf Comput Sci. 2004; 44(2):699-703. DOI: 10.1021/ci034246+. View

4.
Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

5.
Wang R, Fang X, Lu Y, Yang C, Wang S . The PDBbind database: methodologies and updates. J Med Chem. 2005; 48(12):4111-9. DOI: 10.1021/jm048957q. View